Carbonic anhydrase inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carbonic anhydrase inhibitor (investigational), covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma [Phase 1]